Transoral Daytime Neuromuscular Electrical Stimulation in Patients With Simple Snoring
- Conditions
- Sleep Apnea, ObstructiveSnoringSleep ApneaSleep
- Interventions
- Device: Transoral Neurostimulation Device (Snoozeal)
- Registration Number
- NCT03913494
- Lead Sponsor
- University of California, San Diego
- Brief Summary
Sleep Disordered Breathing (SDB) is a spectrum of conditions spanning from Simple Snoring to Severe Sleep apnea. SDB has multiple underlying mechanisms. Some portion of patients have issues with upper airway dilator muscle control; and such patients may be amenable to upper airway muscle training exercises using neuromuscular stimulation techniques. The investigators and others have published on the topic of neuromyopathy in the upper airway, defining a subgroup of OSA patients who may be amenable to training exercises. Based on this background, the investigators seek to test the hypothesis that upper airway tongue muscle training using transoral surface neuromuscular electrical stimulation may have benefits to patients with Simple Snoring.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 48
• Confirmation of snoring: must have a live-in bed partner that reports ≥ 6 months history of habitual snoring (i.e. > 5 days per week)
- AHI > 15/hr
- BMI > 35
- Non-English speakers (due to necessity to complete questionnaires)
- Inability to complete daily neuromuscular stimulation
- Other sleep disorders
- Tongue or lip piercing
- Pacemaker of implanted medical electrical devices
- Current or recent (within last 6 months) treatment for snoring or sleep apnea
- Previous oral or pharyngeal surgery other than dental
- Craniofacial skeletal or muscular abnormalities
- History of driving or other accidents due to sleepiness or an Epworth score (ESS)> 18
- Pregnant
- Cardiac (other than hypertension), pulmonary, renal, neurologic, neuromuscular or hepatic disease
- Medications with sedative or myorelaxant properties or effects on cardiac or pulmonary function
- Substantial alcohol (>3oz/day) or use of illicit drugs
- Psychiatric disorders (other than depression or anxiety)
- Snoring less than 20% of total sleep time during baseline polysomnography
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 4 Week Snoozeal Use Transoral Neurostimulation Device (Snoozeal) Participants will take the device home and be required to use it for 20 minutes morning and night every day for at least 4 weeks. The SnooZeal records usage time to allow assessment of compliance.
- Primary Outcome Measures
Name Time Method NREM EMGgg 6 hours Genioglossal muscle activity as measured by two 25 gauge needles each containing a Teflon-coated stainless steel recording wire (\<0.1 mm in diameter with \~1 mm at the tip bared of Teflon and bent to form a small hook) placed perorally 1.5-2 cm into the body of the genioglossus muscle.
Change in percent total sleep time spent snoring 6 hours Time spent snoring divided by total sleep time as determined by Polysomnogram
- Secondary Outcome Measures
Name Time Method Sleep Quality 10 minutes A self-report questionnaire, titled the Pittsburgh Quality of Sleep Questionnaire (PSQI), asking several questions to determine quality of sleep over the past 1 month that will be scored and added together on a scale of 0-21.
Daytime Sleepiness 10 minutes A self-report questionnaire, titled the Epworth Sleepiness Scale (ESS), asking subjects to rate their probability of falling asleep during different situations on a scale of 0-3. Scores are added together to determine how sleepy the subject feels during the day on a scale of 0-24
Trial Locations
- Locations (2)
University of California San Diego
🇺🇸San Diego, California, United States
Altman Clinical and Translational Research Institute
🇺🇸San Diego, California, United States